US2998436A - Intermediates in the conversion of 11-ketodiosgenin to cortisone - Google Patents
Intermediates in the conversion of 11-ketodiosgenin to cortisone Download PDFInfo
- Publication number
- US2998436A US2998436A US644184A US64418457A US2998436A US 2998436 A US2998436 A US 2998436A US 644184 A US644184 A US 644184A US 64418457 A US64418457 A US 64418457A US 2998436 A US2998436 A US 2998436A
- Authority
- US
- United States
- Prior art keywords
- dione
- pregnene
- cortisone
- hydroxy
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 title description 13
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 title description 13
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 title description 13
- 229960004544 cortisone Drugs 0.000 title description 13
- 238000006243 chemical reaction Methods 0.000 title description 7
- 239000000543 intermediate Substances 0.000 title description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- 150000001875 compounds Chemical class 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 5
- VZRAKVPDZIQRGT-WZBAXQLOSA-N (8r,9s,10s,13r,14s,17r)-17-ethenyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C=C)[C@@H]4[C@@H]3CCC21 VZRAKVPDZIQRGT-WZBAXQLOSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052794 bromium Inorganic materials 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DWCSNWXARWMZTG-UHFFFAOYSA-N Trigonegenin A Natural products CC1C(C2(CCC3C4(C)CCC(O)C=C4CCC3C2C2)C)C2OC11CCC(C)CO1 DWCSNWXARWMZTG-UHFFFAOYSA-N 0.000 description 3
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000003431 steroids Chemical class 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UVLDESQWQRMYKD-UHFFFAOYSA-N Neobotogenin Natural products CC1C(C2(C(=O)CC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 UVLDESQWQRMYKD-UHFFFAOYSA-N 0.000 description 2
- 238000006036 Oppenauer oxidation reaction Methods 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- MUCRYNWJQNHDJH-OADIDDRXSA-N Ursonic acid Chemical class C1CC(=O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C MUCRYNWJQNHDJH-OADIDDRXSA-N 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 229940093499 ethyl acetate Drugs 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- -1 keto diosgenin Chemical compound 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- CZCROZIJKBXZDP-UHFFFAOYSA-N yamogenin acetate Natural products CC1C(C2(CCC3C4(C)CCC(CC4=CCC3C2C2)OC(C)=O)C)C2OC11CCC(C)CO1 CZCROZIJKBXZDP-UHFFFAOYSA-N 0.000 description 2
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 1
- NYZPTLBOPZZLRX-KJQYFISQSA-N (8S,9S,10R,13S,14S,17S)-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,3,4,7,8,9,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-11-one Chemical compound OCC([C@H]1CC[C@H]2[C@@H]3CC=C4CCCC[C@]4(C)[C@H]3C(C[C@]12C)=O)=O NYZPTLBOPZZLRX-KJQYFISQSA-N 0.000 description 1
- CPUKWYXYHPOQJH-RDQPJNLGSA-N (8r,9s,10s,13s,14s)-17-ethenyl-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CCC[C@]2(C)[C@H]3CC[C@](C)(C(=CC4)C=C)[C@@H]4[C@@H]3CCC21 CPUKWYXYHPOQJH-RDQPJNLGSA-N 0.000 description 1
- FJNCXZZQNBKEJT-UHFFFAOYSA-N 8beta-hydroxymarrubiin Natural products O1C(=O)C2(C)CCCC3(C)C2C1CC(C)(O)C3(O)CCC=1C=COC=1 FJNCXZZQNBKEJT-UHFFFAOYSA-N 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical class C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- RXCLXOHQWLORQY-UHFFFAOYSA-N Gentrogenin Natural products CC1CCC2(OC1)OC3CC4C5CCC6=CC(O)CCC6(C)C5CC(=O)C4(C)C3C2C RXCLXOHQWLORQY-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- RTMWIZOXNKJHRE-UHFFFAOYSA-N Tigogenin Natural products CC1COC2CC(C)(OC12)C3CCC4C5CCC6CC(O)CCC6(C)C5CCC34C RTMWIZOXNKJHRE-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical compound [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 238000007256 debromination reaction Methods 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- WQLVFSAGQJTQCK-VKROHFNGSA-N diosgenin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 WQLVFSAGQJTQCK-VKROHFNGSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- UVLDESQWQRMYKD-MOAZMYQBSA-N gentrogenin Chemical compound O([C@@H]1[C@@H]([C@]2(C(=O)C[C@@H]3[C@@]4(C)CC[C@H](O)CC4=CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVLDESQWQRMYKD-MOAZMYQBSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000002924 oxiranes Chemical class 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000008259 solid foam Substances 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 238000000844 transformation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Definitions
- the product is saponified in nearly diosgenin can be converted to cortisone via a new route 100% yield to 16oz,170t-6pOXy-3ot-hYdIOXY-S-Pl6gl16fl6- involving new intermediates in which full advantage of 11,20-dione, IV.
- Treatment of this material with hydrothe naturally occurring 3-hydroxy 5,6-olefinic functional bromic acid followed by Raney nickel debromination group system can be made.
- Among the advantages of produces 3,6,17a-dihydroxy-5-pregnene-11,20-dione, V, in the 3-hydroxy 5,6-olefinic system is the ease with which 70% yield for the two steps.
- This material is formylated it can be converted in a one step, high-yield Oppenauer at the (3-3 hydroxy group in 80% yield to give 3 8-foroxidation to the A -3 ketone system necessary for the moxy-l7a-hydroxy-5-pregnene-l1,20-di0ne, V1.
- This one step conversion contrasts with the multiwould be expected to saturate the 5,6-olefinic bond since, ple operations necessary in converting the 11-keto tigoin general, addition reactions are more rapid than subgenin derivative to the A -3 ketone system in the comstitution reactions.
- Acetylation of this compound either by long refluxing with acetic anhydride or by 18-hour treatment at room temperature with an acetylation catalyst such as p-toluene sulfonic acid or perchloric acid gives 1711,21 diacetoxy 3,8 formoxy-S-pregnene-l1,20- dione, VIII.
- an acetylation catalyst such as p-toluene sulfonic acid or perchloric acid gives 1711,21 diacetoxy 3,8 formoxy-S-pregnene-l1,20- dione, VIII.
- an acetylation catalyst such as p-toluene sulfonic acid or perchloric acid gives 1711,21 diacetoxy 3,8 formoxy-S-pregnene-l1,20- dione, VIII.
- p-toluene sulfonic acid or perchloric acid gives 1711,21 diacetoxy 3,8 formoxy-S-pregnene-l
- cortisone 17a,21-diacetate X. All compounds preceding cortisone 17a,21-diacetate in this series of transformations are new compounds not previously described. Hydrolysis of cortisone diacetate produces cortisone, XI, an important hormone of. known utility.
- the mother liquors from this preparation were also used since they gave crystalline epoxide when treated as in Example 2.
- the total yield of crystalline product was 55 mole percent.
- EXAMPLE IV 21-acet0xy-3B-formoxy-1 7a-hydroxy-5-pregnene-I1,20- dione.
- the preceding formate 1.253 g. (0.00334 mole) was dissolved in 25 ml. of dry methylene chloride and the solution was treated with 13.32 ml. of a solution of bromine (0.00334 moles) in 13.32 ml. of methylene chloride. The volume was reduced by distillation in vacuo at 30; the solution was washed with 1% sodium hydrogen carbonate solution; and the solvents removed in vacuo. The residue' was dissolved in acetone, 25 ml. and 2 g. of sodium iodide were added.
- EXAMPLE VI ,21 diacetoxy 319 formoxy 5 pregnene II, 20-dione.-The preceding compound, 99 mg., in 0.71 ml.
- EXAMPLE VII Corrisone 17a,21-diacetate and cortisone.Eight hundred milligrams of the uncrystallized mother liquor residues from Example 6 consisting essentially of a mixture of the 3-hydroxy and 3-formoxyl compounds were dissolved in 25 ml. of dry toluene. Eight ml. of cyclohexanone and 840 mg. of aluminum isopropoxide were added and the mixture was refluxed for 0.75 hour, cooled and water was added. The contents of the flask were heated until organic solvents were lost, and the gummy solid was collected by extraction with ether. Evaporation of the ether in vacuo and crystallization of the residue from methanol gave 400 mg. of cortisone, 1704,21- diacetate, X, M.P. 220-221",
- EXAMPLE VIII Two hundred milligrams of crystalline, 17u,21-diacetoxy 3B-formoxy-5-pregnene-l1,20-dione, VIII, in 20 m1. of dry toluene, 300 mg. aluminum isopropoxide and 2 m1. of cyclohexanone were refluxed for minutes. Water, 100 ml, was added and the two-phase mixture was boiled until all organic solvents had been carried ofl in the vapors. The residue was collected as a pasty mass by decantation of the water. Crystallization from methanol gave a yield of cortisone, 17a,-21diacetate, X.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
United States Patent G 2,998,436 INTERMEDIATES IN THE CONVERSION OF ll-KETODIOSGENIN T 'CORTISONE Edward S. Rothman, Philadelphia, and Monroe E. Wall,
Oreland, Pa., assignors to the United States of America as represented by the Secretary of Agriculture No. Drawing. Filed Mar. 5, 1957, Ser. No. 644,184
5 Claims. (Cl. 260-39145) (Granted under Title 35, US. Code (1952), sec. 266) A non-exclusive, irrevocable, royalty-free license in the invention herein described, throughout the world for all purposes of the United States Government, with power to grant sublicenses for such purposes, is hereby 2,998,436 l atented Aug. 29, 1961 c ce The advantage of our process lies in the avoidance of these multiple, low-yielding steps.
Our invention will now be described with reference to granted to the Government of the United States of Amerthe following diagrams:
FLOW SHEET OF CHEMICAL TRANSFORMATION CH3 CH3 CH! 0H, CH8
0 of 0 0 v CH CH CH" ---v -----p -v AcO AcO R0 CHzOR --OR! 0 0 of CH CH CH v R==H VII R=HCO; R==H X R=R'=CH.5CO v1 R=HCO VIII R=HCO; R=OH O0 XI R=R=H Ix R=H; R=CHaCO ica. In co -pending patent applications Serial Numbers Inour process we degrade ll-keto diosgenin acetate, 566,737, filed February 20, 1956, now US. Patent 1, by a process well-known to those familiar with the art 2,830,986 and 644,183, filed March 5, 1957, now US. to the new compound 3B-acetoxy-5,l6-pregnadiene-11,20- Patent 2,899,428, steroidal sapogenins' gentrogenin and dione, II. It is neither desirable or necessary to isolate its C- diastereoisomer correllogenin were described intermediates in the course of this transformation of and were converted to the new steroidal sapogenin, 11- s-apogenin to pregnadiene. The product, isolated in keto diosgenin. When ll-keto diosgenin is converted to yield or better, is treated with alkaline hydrogen peroxide cortisone via ll-keto tigogenin, the advantages of its to selectively epoxidize only the 16-17 olefinic bond to olefinic functional group are wasted in so doing. It is form 3,8- acetoxy-loa,17a-epoxy-5-pregnene-11,20-dione, the purpose of the present disclosure to show that ll-keto 55 III, in 84% yield. The product is saponified in nearly diosgenin can be converted to cortisone via a new route 100% yield to 16oz,170t-6pOXy-3ot-hYdIOXY-S-Pl6gl16fl6- involving new intermediates in which full advantage of 11,20-dione, IV. Treatment of this material with hydrothe naturally occurring 3-hydroxy 5,6-olefinic functional bromic acid followed by Raney nickel debromination group system can be made. Among the advantages of produces 3,6,17a-dihydroxy-5-pregnene-11,20-dione, V, in the 3-hydroxy 5,6-olefinic system is the ease with which 70% yield for the two steps. This material is formylated it can be converted in a one step, high-yield Oppenauer at the (3-3 hydroxy group in 80% yield to give 3 8-foroxidation to the A -3 ketone system necessary for the moxy-l7a-hydroxy-5-pregnene-l1,20-di0ne, V1. Treatphysiological adrenal cortical hormone activity of cortiment of the formate with one molar equivalent of bromine: sone. This one step conversion contrasts with the multiwould be expected to saturate the 5,6-olefinic bond since, ple operations necessary in converting the 11-keto tigoin general, addition reactions are more rapid than subgenin derivative to the A -3 ketone system in the comstitution reactions. Surprisingly, this expected reaction mercial processes. These multiple operations involve of double bond saturation does not occur to any major; (1) oxidation to the saturated 3-ketone, (2) dibrominaextent. Instead substitution on the C-21 methyl, group tion at the 2 and 4 positions, (3) reaction with sodium occurs. Lowered yields are obtained if more, than one iodide to simultaneously metathetically replace the C-2 mole of bromine is added; therefore, excess bromine is,
bromine atom with an iodine atom and establish a A bond and (4) finally to reductively remove the iodine to be avoided. Treatment of the bromination product with sodium iodide followed by a subsequent, separate asasnse treatment with sodium or potassium acetate gives the diester, 21-acetoxy-3/3-formoxy-17a-hydroxy-5-pregnene- 11,20-dione, VII. Acetylation of this compound either by long refluxing with acetic anhydride or by 18-hour treatment at room temperature with an acetylation catalyst such as p-toluene sulfonic acid or perchloric acid gives 1711,21 diacetoxy 3,8 formoxy-S-pregnene-l1,20- dione, VIII. In the course of isolation some hydrolytic loss of formate sometimes occurs to form 17,21-diacetoxy-3B-hydroxy 5 pregnene 11,20 dione, IX, but this offers no disadvantage since both 3B-hydroxyl group and the 3,8-formoxyl group behave alike to the mildly alkaline aluminum isopropoxide Oppenauer reagent, and form the same 3-ketone. This Oppenauer oxidation product. of the 3-formate or of the 3-hydroxyl compound or of'their mixtures produces the known cortisone 17a,21-diacetate, X. All compounds preceding cortisone 17a,21-diacetate in this series of transformations are new compounds not previously described. Hydrolysis of cortisone diacetate produces cortisone, XI, an important hormone of. known utility.
EXAMPLE I Degradation of II-keto diosgenin acetate.In a 250 ml. thick glass bottle fitted with a wired-on, gas-tight,
ground-glass stopper were placed 14.5 g. of ll-keto dilog e=3.93. The mother liquors from this preparation were also used since they gave crystalline epoxide when treated as in Example 2. The total yield of crystalline product was 55 mole percent.
Calcd. for C H O C, 74.56; H, 8.16. Found: C, 74.36; H, 8.33.
When the product, was crystallized from methanol a molecule of solvent was bound to each molecule of steroid by solvation.
EMMPLE II .ifi-acetoxy-l 6a,] 7a-epoxy-5-pregnene-H ,20 dine.A 5.95 g. sample of the preceding preparation was dissolved in 800 ml. of methanol at 10 C., ml. of 30% hydrogen peroxide and 2.3 m1. of 4 N sodium hydroxide were added and the mixture was stored overnight. A crystalline water-insoluble precipitate formed and was filtered off. The filtrate was diluted with an equal volume of water and a new crop crystals formed and were filtered off. The filtrate was neutralized with hydrochloric acid and was well-extracted with methylene chloride which was evaporated to give a glassy residue. All solids were combed and converted to acetates by dissolving in 30 ml. of pyridine and. ml. of acetic anhydride and heating 0.75 hour on the steambath. On dilution with water and isolation by ether extraction 5.1 g. of ethanol recrystallized product were obtained (84% yield). The product was freed of 100 mg. of an unidentified extremely insoluble material (M.P. 318) by solution in ethyl acetate, filtering and crystallizing by evaporation to dryness. The product melted from 205206 C. forming dense polyhedra undergoing transition on the Kofler block to refractile, tetragonal prisms, [a] =+14.8.
Calcd. for C H O C, 71.48; H, 7.82. Found: C, 71.46; H, 8.08.
Saponification with 5% methanolic potassium hydroxide gave 4.46 g. of 16a,17a-epoxy-3fi-hydroxy-S-pregnene- 11,20-dione, IV, M.P. 111 to about 114 when crystallized from ethanol. Perhaps the molecule thus crystallized is solvated but the lower indicated melting temperature is characteristic.
Calcd. for C H o C, 73.22; H, 819. Found: C, 73.98; H, 8.01.
EXAMPLE HI 33,1Zu-dihydrOxy-S-pregnene-l],20-dione.To a. solution of 2.22 g. of 16a,l7a-epoxy-3fi-hydroxy-5-pregnene- 11,20-dione, IV, in 22 ml. of acetic acid was added 4.3 ml. of a 40% solution of hydrogen bromide in acetic acid. After standing for 25 minutes the reaction mixture was poured into ml. of cold Water and the precipitated bromohydrine was filtered off and air dried. Ten grams of Raney nickel was heated with 100 ml. of refluxing acetone. Ten ml. of Water, two ml. of acetic acid, and the crude bromohydrin were added and stirring and heating under reflux was maintained for 4 hours. The acetone solution was decanted and evaporated to dryness in vacuo. Crystallization of the residue from methylene chloride and from ethylacetate gave 1.57 g. (71% yield) of 313,17a-dihydroxy-S-pregnene-l1,20-dione, V. The compound formed dense polyhedral crystals, M.P. 277278 C. after transition over 220 to lance forms [a] +6 (MeOH).
Calcd. for (2 113004: C, H, 8.73. 72.41; H, 8.69.
Found: C.
EXAMPLE IV EXAMPLE V 21-acet0xy-3B-formoxy-1 7a-hydroxy-5-pregnene-I1,20- dione.The preceding formate 1.253 g. (0.00334 mole) Was dissolved in 25 ml. of dry methylene chloride and the solution was treated with 13.32 ml. of a solution of bromine (0.00334 moles) in 13.32 ml. of methylene chloride. The volume was reduced by distillation in vacuo at 30; the solution was washed with 1% sodium hydrogen carbonate solution; and the solvents removed in vacuo. The residue' was dissolved in acetone, 25 ml. and 2 g. of sodium iodide were added. The mixture was let stand overnight and was then poured into a cold solution of 2 g. of sodium thiosulfate in 70 ml. of water. The steroid was filtered 011 and dried in vacuo at room temperature. The crude iodo compound was dissolved in 25 ml. of dry acetone, 2.5 g. of potassium acetate was added and the mixture was heated under reflux and with stirring for 18 hours. The reaction mixture was cooled, poured into water and the steroid was isolated by extraction with ether. Evaporation of the ether in vacuo gave a colorless solid foam. Chromatography of this material with chloroform elution gave only 540 mg. of the desired crystalline, 21 acetoxy-3fl-formoxy-17a-hydroxy-5-preg nene-11,20-dione, VII, M.P. 192.5-193.5, red melt, [d] +20.8, but the colorless glassy residues eluted just after the crystalline material gave 100 mg. of the 1712 acetoxyl derivative, VIII, when treated as in Example VI.
Calcd. for C H O C, 66.65; H, 7.46. Found: C, 66.41; H,.7144.
EXAMPLE VI :,21 diacetoxy 319 formoxy 5 pregnene II, 20-dione.-The preceding compound, 99 mg., in 0.71 ml.
of acetic anhydride was treated with 31.4 mg. of p-toluene sulfonic acid at room temperature overnight. On decomposing with water an amorphous solid was obtained which on chromatography on Florisil gave 80 mg. of crystallizable material. The earlier benzene-eluted 17a, 21 diacetoxy 35 formoxy 5 pregnene 11,20-dione, VIII, [a] =+40 melts with decomposition from 228 to 229, occasionally from 233 to 235, and shows no hydroxyl band in the infrared spectrum, a broad multiple ketonic band and a series of ester bands at 1237, 1250, and 1260 cmf The chloroform eluate gave 17a,21- diacetoxy-3B-hydroxy-5-pregnene-11,20-dione, IX, M.P. 203-205 C., [a] =+83 showing infrared hydroxyl bands at 3410 and 3500 cm? (KBr disc), broad ketone bands centered at 1705 and 1731 cm? and a strong, sharp ester band centered at 1258 cm. with a small band at 124-5 cmf Non-crystallizable mother liquor residues were saved and carried through the Oppenauer oxidation reaction indicated in Example 7.
Compound VIII, calcd. for C H O C, 65.80; H, 7.22. Found: C, 65.50; H, 7.21.
Compound IX, calcd. for C H O C, 67.24; H, 7.68. Found: C, 67.02; H, 7.60.
EXAMPLE VII Corrisone 17a,21-diacetate and cortisone.Eight hundred milligrams of the uncrystallized mother liquor residues from Example 6 consisting essentially of a mixture of the 3-hydroxy and 3-formoxyl compounds were dissolved in 25 ml. of dry toluene. Eight ml. of cyclohexanone and 840 mg. of aluminum isopropoxide were added and the mixture was refluxed for 0.75 hour, cooled and water was added. The contents of the flask were heated until organic solvents were lost, and the gummy solid was collected by extraction with ether. Evaporation of the ether in vacuo and crystallization of the residue from methanol gave 400 mg. of cortisone, 1704,21- diacetate, X, M.P. 220-221",
ll??? 238 u e=35,000, identical with an authentic specimen. Hydrolysis of cortisone diacetate in 5% sodium hydroxide in methanol gave an 80% yield of cortisone, XI, identical with an authentic specimen.
EXAMPLE VIII Two hundred milligrams of crystalline, 17u,21-diacetoxy 3B-formoxy-5-pregnene-l1,20-dione, VIII, in 20 m1. of dry toluene, 300 mg. aluminum isopropoxide and 2 m1. of cyclohexanone were refluxed for minutes. Water, 100 ml, was added and the two-phase mixture was boiled until all organic solvents had been carried ofl in the vapors. The residue was collected as a pasty mass by decantation of the water. Crystallization from methanol gave a yield of cortisone, 17a,-21diacetate, X.
We claim:
1. 3B,17a-dihydroxy-5-pregnene-11,20-dione.
2. 3p formoxy 17a hydroxy 5 pregnene 11,20- dione.
3. 21 acetoxy 3,8 fonnoxy 17a hydroxy 5- pregnene- 1 1,20-dione.
4. 17a,21 diacetoxy 3p formoxy 5 pregnene- 11,20-dione.
5. 17a,21 diacetoxy 3,8 hydroxy 5 pregnene- 11,20-dione.
References Cited in the file of this patent .UNITED STATES PATENTS 2,596,563 Kaufmann May 13, 1952 2,667,498 Julian Ian. 26, 1954 2,668,816 Miescher Feb. 9, 1954- 2,684,364 Jones July 20, 1954 2,686,181 Julian Aug. 10, 1954 2,787,623 Gebert Apr. 2, 1957 2,805,230 Stork Sept. 3, 1957 2,857,404 Gash Oct. 21, 1958 2,874,172 Herzog et a1 Feb. 17, 1959 2,883,403 Rothman et al. Apr. 21, 1959 OTHER REFERENCES Djerassi: Chem. Abstracts, 1955, p. 7585, vol. 49. Wall et al.: J.A.C.S., vol. 77, pages 5665-68 (1955). Ringold et al.: J. Am. Chem. 800., 78, 816-819 (1956).
Claims (1)
1. 3B,17A-DIHYDROXY-5-PREGNENE-11,20-DIONE.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US644184A US2998436A (en) | 1957-03-05 | 1957-03-05 | Intermediates in the conversion of 11-ketodiosgenin to cortisone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US644184A US2998436A (en) | 1957-03-05 | 1957-03-05 | Intermediates in the conversion of 11-ketodiosgenin to cortisone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2998436A true US2998436A (en) | 1961-08-29 |
Family
ID=24583807
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US644184A Expired - Lifetime US2998436A (en) | 1957-03-05 | 1957-03-05 | Intermediates in the conversion of 11-ketodiosgenin to cortisone |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2998436A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3084157A (en) * | 1957-10-15 | 1963-04-02 | Syntex Corp | Process for the production of 6alpha-fluorocortisone and intermediates therein |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2596563A (en) * | 1950-10-30 | 1952-05-13 | Syntex Sa | Process for producing 17-hydroxy-20-keto-21-acyloxy pregnanes |
| US2667498A (en) * | 1949-09-17 | 1954-01-26 | Glidden Co | Selective dehalogenation of certain halogenated ketones |
| US2668816A (en) * | 1950-02-10 | 1954-02-09 | Ciba Pharm Prod Inc | Process for the preparation of 17, 20-hydroxyketones of the pregnane series and new and useful compounds of the said series |
| US2684364A (en) * | 1950-03-11 | 1954-07-20 | Parke Davis & Co | Oxidosteroids and preparation of same |
| US2686181A (en) * | 1949-08-11 | 1954-08-10 | Glidden Co | 16, 17-oxido-5-pregnenes and method of preparing |
| US2787623A (en) * | 1954-09-30 | 1957-04-02 | William H Gebert | Reduction of 16-iodopregnane compounds |
| US2805230A (en) * | 1952-08-02 | 1957-09-03 | Syntex Sa | Esters of 17alpha-hydroxy progesterone |
| US2857404A (en) * | 1955-11-18 | 1958-10-21 | Monsanto Chemicals | Steroid esters and method of making same |
| US2874172A (en) * | 1955-01-26 | 1959-02-17 | Schering Corp | 11-oxygenated 1, 4, 16-pregnatriene-21-ol-3, 20 diones and esters thereof |
| US2883403A (en) * | 1958-03-04 | 1959-04-21 | Edward S Rothman | Process for conversion of 3beta,17alpha-dihydroxy-5-pregnene-11,20-dione to cortisone acetate |
-
1957
- 1957-03-05 US US644184A patent/US2998436A/en not_active Expired - Lifetime
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2686181A (en) * | 1949-08-11 | 1954-08-10 | Glidden Co | 16, 17-oxido-5-pregnenes and method of preparing |
| US2667498A (en) * | 1949-09-17 | 1954-01-26 | Glidden Co | Selective dehalogenation of certain halogenated ketones |
| US2668816A (en) * | 1950-02-10 | 1954-02-09 | Ciba Pharm Prod Inc | Process for the preparation of 17, 20-hydroxyketones of the pregnane series and new and useful compounds of the said series |
| US2684364A (en) * | 1950-03-11 | 1954-07-20 | Parke Davis & Co | Oxidosteroids and preparation of same |
| US2596563A (en) * | 1950-10-30 | 1952-05-13 | Syntex Sa | Process for producing 17-hydroxy-20-keto-21-acyloxy pregnanes |
| US2805230A (en) * | 1952-08-02 | 1957-09-03 | Syntex Sa | Esters of 17alpha-hydroxy progesterone |
| US2787623A (en) * | 1954-09-30 | 1957-04-02 | William H Gebert | Reduction of 16-iodopregnane compounds |
| US2874172A (en) * | 1955-01-26 | 1959-02-17 | Schering Corp | 11-oxygenated 1, 4, 16-pregnatriene-21-ol-3, 20 diones and esters thereof |
| US2857404A (en) * | 1955-11-18 | 1958-10-21 | Monsanto Chemicals | Steroid esters and method of making same |
| US2883403A (en) * | 1958-03-04 | 1959-04-21 | Edward S Rothman | Process for conversion of 3beta,17alpha-dihydroxy-5-pregnene-11,20-dione to cortisone acetate |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3084157A (en) * | 1957-10-15 | 1963-04-02 | Syntex Corp | Process for the production of 6alpha-fluorocortisone and intermediates therein |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2805230A (en) | Esters of 17alpha-hydroxy progesterone | |
| US2790814A (en) | Steroid production | |
| Djerassi et al. | Steroidal Sapogenins. XVI. 1a Introduction of the 11-Keto and 11α-Hydroxy Groups into Ring C Unsubstituted Steroids (Part 3). 1b 11-Oxygenated Sapogenins | |
| US2734897A (en) | Chacoo | |
| US2705233A (en) | 16, 17-oxido-pregnane-3alpha-ol-3, 20-dione | |
| US2874154A (en) | Process for the production of 20-keto-21-iodo steroids | |
| US2998436A (en) | Intermediates in the conversion of 11-ketodiosgenin to cortisone | |
| US2774776A (en) | Dihalosteroids | |
| US2900382A (en) | Method of making delta4,6 steroid compounds from delta4 steroid compounds | |
| US2786855A (en) | Oxidation of delta4-3, 6-dihydroxy steroids to delta4-3-keto-6-hydroxy steroids | |
| US2769823A (en) | Preparation of 17alpha-hydroxy-20-keto-pregnenes | |
| US2863862A (en) | 1-methyl steroid derivatives and method for the production thereof | |
| US3056809A (en) | Method for introducing an oxygen function into a steroid molecule containing an enol group and compounds thereof | |
| US3062846A (en) | (lower alkoxy) methyl ether derivatives of steroids and process therefor | |
| US2862011A (en) | Production of 2-bromo-keto-11-oxygenated-4,17-(20)-pregnadiene-21-oic acid esters | |
| US3255218A (en) | 17(20)-enol-21-aldehydes of the pregnane series | |
| US2877242A (en) | Method of preparing 11 beta-hydroxy testosterone | |
| US2982767A (en) | 18-oxygenated pregnanes | |
| US3305546A (en) | Process for the production of 16-halo-17(20)-pregnenes | |
| Harnik | Studies in Syntheses of Steroid Metabolites. II | |
| US3062844A (en) | 6-methyl-3-oxo-4:6-dienic steroids | |
| US3057858A (en) | 6alpha-substituted-16beta-methyl-11-epihydrocortisone | |
| US3006931A (en) | Estratriene series compounds and their production | |
| US3000911A (en) | 9alpha-fluoro-12beta-hydroxy derivatives of the pregnane series | |
| US2982776A (en) | 16alpha-methylpregnane derivatives and processes for preparing the same |